- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Syncor signs Israeli radiopharmacy deal
Radiopharmacy firm Syncor International of Woodland Hills, CA, has agreed to license its technology to Israeli nuclear research agency Soreq and its subsidiary, Isorad, which plan to establish a radiopharmacy in Israel. In exchange for providing
Radiopharmacy firm Syncor International of Woodland Hills, CA, has agreed to license its technology to Israeli nuclear research agency Soreq and its subsidiary, Isorad, which plan to establish a radiopharmacy in Israel. In exchange for providing information and technical assistance to set up the radiopharmacy, Syncor will receive quarterly payments. Soreq is affiliated with the Israel Atomic Energy Commission and carries out advanced R&D projects, while Isorad sells and markets Soreq products to private businesses.
New Study Assesses Benefits of High-Resolution Photon-Counting for Computed Tomography Angiography
October 10th 2024Researchers found that ultra-high resolution photon-counting significantly enhanced visualization of small vessels and facilitated improved reduction of blooming artifacts for head and neck computed tomography angiography (CTA) scans.
FDA Clears Software for Enhancing CCTA Assessment of Atherosclerosis
October 1st 2024Through analysis of coronary computed tomography angiography (CCTA) images, the PlaqueIQ software provides quantification and classification of atherosclerosis, a common cause of myocardial infarction (MI) and ischemic stroke.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can Intestinal Ultrasound Provide an Alternative for Evaluating Creeping Fat with Crohn’s Disease?
September 25th 2024Intestinal ultrasound demonstrated an 88.2 percent agreement with computed tomography enterography in characterizing creeping fat in patients with Crohn’s disease, according to new research.
